CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 7(Granted Patents)

Company Filing History:

Beta Pharma (shanghai) Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187707 - Pharmaceutical formulations of-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylaminde and salts thereof (2025-01-07),

2. 11414401 - Substituted 2-anilinopyrimidine derivatives as EGFR modulators (2022-08-16),

3. 11180478 - Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof (2021-11-23),

4. 11052086 - 2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers (2021-07-06),

5. 10844045 - Pharmaceutical salts N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and crystalline forms thereof (2020-11-24),

6. 10590111 - Substituted 2-anilinopyrimidine derivatives as EGFR modulators (2020-03-17),

7. 10239864 - 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof (2019-03-26),

8. 9878994 - 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof (2018-01-30),

Certainly! Here is an article about the accomplished inventor Victoria Lynn Wilde:

Title: Unveiling the Innovative Mind of Victoria Lynn Wilde

Introduction:

Victoria Lynn Wilde, a visionary inventor hailing from Montclair, NJ (US), has made significant contributions to the field of healthcare with her groundbreaking patents. With a total of 7 patents to her name, Victoria's journey in revolutionizing medical treatments is nothing short of inspiring.

Latest Patents:

Victoria's latest patents showcase her expertise in developing cutting-edge pharmaceutical formulations for the treatment and prevention of diseases mediated by epidermal growth factor receptors (EGFRs). Notably, her inventions include novel substituted 2-anilinopyrimidine derivatives and pharmaceutical formulations that target mutated forms of EGFR to combat various cancers.

Career Highlights:

Victoria Lynn Wilde has made impactful contributions during her tenure at prestigious companies such as Beta Pharma, Inc. and Beta Pharma (Shanghai) Co., Ltd. Her innovative approaches and dedication to advancing medical science have earned her recognition as a key figure in the pharmaceutical industry.

Collaborations:

Throughout her career, Victoria has worked closely with esteemed colleagues, including Michael Nicholas Greco and Michael John Costanzo. The collaborative efforts of these talented individuals have led to the development of pioneering solutions that have the potential to transform the landscape of healthcare.

Conclusion:

In conclusion, Victoria Lynn Wilde's remarkable journey as an inventor showcases her unwavering commitment to driving innovation in the healthcare sector. Her groundbreaking patents and collaborations stand as a testament to her visionary mindset and passion for creating meaningful change in the world of medicine. Victoria's work exemplifies the essence of true innovation and serves as an inspiration to aspiring inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.